Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients

QR Code

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients

ObjectiveThis study aimed to discuss the influence of oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer (CRC) patients.MethodsA total of 100 advanced CRC patients, selected from January 2019 to January 2021, were divided into a control group (CG)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan Kuang, Hong Xu, Xiaoming Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Medicine
Subjects:	colorectal cancer oxaliplatin capecitabine chemotherapy comprehensive nursing
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1582683/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immediate and long-term results of radiation therapy in combination with capecitabine and oxaliplatin in the treatment of patients with asquamous cell carcinoma of the anus
by: A. A. Nevolskikh, et al.
Published: (2023-09-01)

Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy
by: Tong Liu, et al.
Published: (2025-12-01)

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report
by: İsmail Beypinar, et al.
Published: (2017-04-01)

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers
by: Anne Dyhl-Polk, et al.
Published: (2025-07-01)

Predictive value of serum miR-21 and miR-122 expression on the efficacy of capecitabine combined with transcatheter hepatic arterial embolization chemotherapy for liver metastasis after colorectal cancer surgery in patients with colorectal cancer and construction and verification of nomograms
by: Wenfang Ma, et al.
Published: (2025-07-01)

DIRAS1 Drives Oxaliplatin Resistance in Colorectal Cancer via PHB1-Mediated Mitochondrial Homeostasis
by: Min Long, et al.
Published: (2025-07-01)

Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study
by: Jing Xue, et al.
Published: (2025-07-01)

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
by: Frankie Ann Holmes, et al.
Published: (2018-06-01)

MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells
by: Hui Liang, et al.
Published: (2019-12-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2024-12-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report
by: Satoshi Yasuda, et al.
Published: (2019-10-01)

Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
by: Reio Ueta, et al.
Published: (2025-07-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Development of an Early-Warning Model for Predicting the Capecitabine-Induced Diarrhea
by: Liu Z, et al.
Published: (2025-06-01)

Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer
by: Meiling Gao, et al.
Published: (2025-07-01)

A Novel Modulator of Resistance for Oxaliplatin-Based Therapy for Colorectal Cancer: The ESCRT Family Member VPS4A
by: Noha M. Abdelrazik, et al.
Published: (2025-06-01)

ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE
by: E. A. Kolomiets, et al.
Published: (2017-12-01)

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
by: Akira Dejima, et al.
Published: (2023-11-01)

The Effect of Arsenic Trioxide and Its Combination with Oxaliplatin and Docetaxel on the Induction of Autophagy and Expression of LC3 and Beclin-1 Genes in AGS and MKN-45 Gastric Cancer Cell Lines
by: Shadi Babaei, et al.
Published: (2025-04-01)

Successful conservative management of massive oxaliplatin extravasation from a central venous port with early systemic corticosteroid therapy
by: Shunsuke Takahagi, et al.
Published: (2025-07-01)

Prophylactic administration of lecithinized superoxide dismutase for a murine model of oxaliplatin-induced myelosuppression
by: Mikako Shimoda, et al.
Published: (2025-07-01)

A Case Report Capecitabine-Induce Grade II Hand and Foot Syndrome
by: Nurul Damayanti, et al.
Published: (2025-07-01)

Drug Delivery by Carbon Nano Carrier for Use as Capecitabine Drug Carrier: A QM/MM study
by: Fahimeh Najafi
Published: (2025-01-01)

A complete response to capecitabine and oxaliplatin chemotherapy in primary duodenal carcinoma with liver and nodal metastases: a case report
by: Seita Hagihara, et al.
Published: (2018-09-01)

Effect of Extra-Virgin Olive Oil on Hand Foot Syndrome and hs-CRP in Patients Receiving Capecitabine: A Randomized Trial
by: Yenny Dian Andayani, et al.
Published: (2024-01-01)

Effect of a supramolecular delivery system based on hyaluronic acid with cyclodextrin on the antitumor properties of oxaliplatin <i>in vitro</i>
by: E. A. Pashkina, et al.
Published: (2024-09-01)

Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type
by: Janice M. Oh, et al.
Published: (2025-07-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

Effectiveness of a Comprehensive Nursing Care Package on Blood Pressure Control in Chennai: A Hospital-Based Study
by: Arockiamary Ignasimuthu, et al.
Published: (2025-06-01)

Association of Comprehensive Nursing with Respiratory Outcomes in Patients Undergoing Tracheostomy After Traumatic Brain Injury
by: Gu XJ, et al.
Published: (2025-07-01)

PTEN and p53 Combined Gene Therapy Promote Apoptosis and Chemosensitivity to Oxaliplatin in Colorectal Cancer: An In Vitro Study
by: Narjes Nakhaee, et al.
Published: (2025-04-01)

PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA
by: A. V. Pavlysh, et al.
Published: (2015-03-01)

Issue of colorectal cancer at the beginning of XXI century: achievements and prospects
by: O. I. Kit
Published: (2013-07-01)

Improvement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach
by: E. O. Kalmykova, et al.
Published: (2024-12-01)

Successful hybrid surgery for ileal conduit stomal varices following oxaliplatin-based chemotherapy in a patient with advanced colorectal cancer
by: Hideo Uehara, et al.
Published: (2020-09-01)

Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
by: Alexander Constantinides, et al.
Published: (2025-09-01)